Diabetes Drug Seeks Approval for Weight Loss

The drug works by suppressing appetite, making it easier for people to stick to a healthy diet and exercise plan.

Screenshot 2023 04 28 At 3 35 50 Pm
Eli Lilly

According to a recent ABC News article, Eli Lilly’s popular Type 2 diabetes drug Mounjaro could be approved for weight loss by the end of 2023. The drug, marketed under the brand name Wegovy, was originally approved as a diabetes medication but has been found to promote weight loss in clinical trials. It is administered via injection once a week and is designed to help people with obesity lose weight and improve their overall health.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Sustainable Healthcare Packaging Solutions That Work